What are bronchoalveolar infiltrates?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What are Bronchoalveolar Infiltrates?

Bronchoalveolar infiltrates refer to abnormal accumulations of cells, fluid, or material within the bronchioles (small airways) and alveoli (air sacs), visible on imaging as opacities that follow a peribronchovascular distribution—meaning they center around airways and blood vessels. 1

Pathologic Basis

The term describes a pattern where disease processes affect both the conducting airways and adjacent alveolar spaces, creating a characteristic distribution on imaging studies. This can result from:

  • Cellular accumulation: Macrophages, lymphocytes, neutrophils, or eosinophils filling the alveolar spaces and bronchiolar lumens 2
  • Fluid accumulation: Edema, hemorrhage, or inflammatory exudate within these structures 3
  • Inflammatory tissue: Granulation tissue plugs extending from bronchioles into alveolar ducts 3

Radiographic Appearance

On Chest X-ray

  • Patchy, bilateral opacities that may appear as diffuse alveolar infiltrates 4
  • Often peripheral or peribronchovascular in distribution 1
  • May present as ground-glass opacities or consolidation 2

On High-Resolution CT (HRCT)

  • Ground-glass opacities: Hazy increased attenuation with preserved bronchial and vascular margins 5
  • Peribronchovascular distribution: Disease centered around airways and vessels 1
  • Tree-in-bud pattern: Small nodular opacities representing bronchiolar inflammation 6
  • Patchy consolidation: Often bilateral and non-segmental 4

Clinical Entities Associated with Bronchoalveolar Infiltrates

Smoking-Related Diseases

  • Desquamative Interstitial Pneumonia (DIP): Uniform, diffuse intraalveolar macrophage accumulation that extends throughout lung parenchyma, accentuated around respiratory bronchioles 2
  • Respiratory Bronchiolitis-ILD (RBILD): Pigmented macrophages within respiratory bronchiole lumens with bronchiolocentric distribution 2

Organizing Pneumonia

  • Intraluminal plugs of granulation tissue in bronchioles extending into alveolar ducts 3
  • Bilateral diffuse alveolar opacities with peripheral distribution 4
  • Patchy consolidation following peribronchovascular pattern 4

Infectious Causes

  • Viral pneumonias: Peribronchovascular distribution with ground-glass opacities 1, 3
  • Atypical pneumonias: Mononuclear inflammatory infiltrate in alveolar septa and interstitial tissue 3
  • Pneumocystis jirovecii: Diffuse bilateral perihilar infiltrates with ground-glass opacities 3

Drug-Induced Pneumonitis

  • Bilateral non-segmental distribution with ground-glass opacities 3
  • Can present as organizing pneumonia pattern 3

Diagnostic Approach

Temporal Pattern Recognition

  • Acute onset (days to weeks) with fever and productive cough suggests infectious pneumonia 1
  • Subacute onset (weeks to months) with dry cough suggests organizing pneumonia or drug-induced disease 1

Laboratory Evaluation

  • Lymphopenia (<0.8 × 10⁹/L) suggests viral etiology and warrants repeat testing in 3 days 1
  • Elevated procalcitonin (>0.10-0.45 ng/mL) and CRP (>50-170 mg/L) indicate bacterial infection 1

Bronchoalveolar Lavage (BAL) Cellular Analysis

When performed, BAL can reveal the specific cellular pattern:

  • >15% lymphocytes: Sarcoidosis, hypersensitivity pneumonitis, drug-induced pneumonitis, organizing pneumonia 2, 3
  • >3% neutrophils: Idiopathic pulmonary fibrosis, acute interstitial pneumonia 2, 3
  • >1% eosinophils: Eosinophilic pneumonia, drug reactions 2, 3
  • Macrophages with smoking-related inclusions: DIP, RBILD 2

A minimal volume of 5 mL pooled BAL sample is needed, with optimal volume of 10-20 mL 2

Critical Pitfalls to Avoid

  • Do not confuse ground-glass opacity with consolidation: In ground-glass opacity, bronchovascular structures remain visible; in consolidation, they are obscured 5
  • Do not assume infection without cultures: Infectious organisms must be excluded through BAL fluid cultures before attributing infiltrates to non-infectious causes 3
  • Do not miss drug-induced disease: This requires drug cessation, not antimicrobials, while organizing pneumonia responds to corticosteroids, not antibiotics 1
  • Reticular or nodular infiltrates on CT have lower BAL diagnostic yield (36.5%) compared to consolidated, ground-glass, or tree-in-bud patterns (61.2%) 6

Expected Evolution

Pneumonic consolidation should progress from patchy consolidation to strip-like opacity, then to grid-like interlobular septal thickening within 2-3 weeks 1. Persistent consolidation beyond 4 weeks warrants bronchoscopy with bronchoalveolar lavage 1.

References

Guideline

Patchy Peribronchovascular Opacities in Pneumonia Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diffuse Interstitial Infiltrates: Etiologies and Diagnostic Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Radiographic Characteristics of Bronchiolitis Obliterans Organizing Pneumonia (BOOP)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the appropriate management for a patient with bilateral opacities, considering their age, medical history, and symptoms such as cough, fever, or shortness of breath?
What are the causes of ground glass opacities (GGO) on radiologic imaging?
What are the causes of peribronchial ground-glass opacities (GGO)?
What is the diagnostic yield of bronchoscopy (Bronchoalveolar Lavage) in oncological adult patients with febrile neutropenia?
What is the most likely microscopic finding in a patient with a history of heavy tobacco use, presenting with progressive breathlessness, mild restrictive lung changes, decreased Diffusing Capacity of the Lung for Carbon Monoxide (DLCO), and diffuse ground-glass opacities on chest Computed Tomography (CT) scan?
What is the recommended oral granisetron dosage for children (excluding infants younger than 12 weeks), including the weight‑based dose, maximum single dose, maximum daily dose, and dosing interval?
What is the most common cause of secondary amenorrhea in women of reproductive age?
What is the pathophysiology of infrarenal aortic cross‑clamping as described in Barash?
What is the recommended terlipressin dose, schedule, duration, and albumin co‑administration for an adult patient with cirrhosis‑related acute kidney injury (hepatorenal syndrome)?
What is the appropriate treatment plan for a patient with intermittent left shoulder pain for one year, provoked by overhead elevation of the arm, who has not used any prior medication?
What does a tiny hypodense focus in the left basal ganglia on a non‑contrast head computed tomography performed six days after a brief 15‑minute episode of transient orientation change without residual motor or sensory deficits represent?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.